Holding(s) in Company

RNS Number : 8906C
Spire Healthcare Group PLC
25 February 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BNLPYF73

Issuer Name

SPIRE HEALTHCARE GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

23-Feb-2022

6. Date on which Issuer notified

25-Feb-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.578449

2.918308

5.496757

22048109

Position of previous notification (if applicable)

2.459454

3.125823

5.585277


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BNLPYF73


10342451


2.578449

Sub Total 8.A

10342451

2.578449%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Right to Recall

N/A

N/A

93227

0.023242

Sub Total 8.B1


93227

0.023242%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swaps

11/04/2022

N/A

Cash

2034000

0.507091

Swaps

24/05/2022

N/A

Cash

2169589

0.540895

Swaps

27/06/2022

N/A

Cash

1847239

0.460530

Swaps

06/07/2022

N/A

Cash

1355000

0.337811

Swaps

29/07/2022

N/A

Cash

4940

0.001232

Swaps

21/09/2022

N/A

Cash

2462

0.000614

Swaps

16/11/2022

N/A

Cash

317447

0.079142

Swaps

30/11/2022

N/A

Cash

2056

0.000513

Swaps

04/01/2023

N/A

Cash

2770859

0.690796

Swaps

31/01/2023

N/A

Cash

16268

0.004056

Swaps

07/02/2023

N/A

Cash

1092000

0.272244

Swaps

27/12/2023

N/A

Cash

571

0.000142

Sub Total 8.B2


11612431

2.895066%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Bank of America Corporation

Merrill Lynch International



5.232854%

Bank of America Corporation

BofA Securities Europe SA




Bank of America Corporation

Bank of America, National Association




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

 

13. Place Of Completion

United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUVAURUKUUUAR
UK 100

Latest directors dealings